Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Xoma Corp
(NQ:
XOMA
)
25.34
-0.16 (-0.63%)
Streaming Delayed Price
Updated: 11:01 AM EDT, May 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Xoma Corp
< Previous
1
2
3
Next >
Stocks That Hit 52-Week Lows On Monday
August 28, 2023
During Monday, 102 stocks hit new 52-week lows.
Via
Benzinga
XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy
August 08, 2023
From
XOMA Corporation
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
July 27, 2023
During Thursday, 56 stocks hit new 52-week lows.
Via
Benzinga
XOMA's Return On Capital Employed Insights
May 24, 2023
Via
Benzinga
XOMA Earnings Perspective: Return On Capital Employed
March 15, 2023
Via
Benzinga
XOMA's Return On Capital Employed Insights
November 24, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
July 26, 2023
Wednesday saw 59 companies set new 52-week lows.
Via
Benzinga
XOMA Added to the Russell 2000® and Russell 3000® Indexes
June 23, 2023
From
XOMA Corporation
Via
GlobeNewswire
Starbucks And 3 Other Stock Insiders Are Buying
September 19, 2022
Although US stocks closed lower on Friday, there were a few notable insider trades.
Via
Benzinga
Recap: XOMA Q4 Earnings
March 08, 2022
XOMA (NASDAQ:XOMA) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA...
Via
Benzinga
Arimoclomol and Aldoxorubicin Acquisition to Bolster XOMA's Revenue Growth: Analyst
June 22, 2023
Earlier today, XOMA Corporation (NASDAQ: XOMA) acquired the royalty and milestone rights associated with two assets from LadRx Corporation: arimoclomol for Niemann-Pick disease type C, and...
Via
Benzinga
XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset
June 22, 2023
New Drug Application for arimoclomol in NPC to be filed as early as the third quarter of 2023¹
From
XOMA Corporation
Via
GlobeNewswire
XOMA Declares Quarterly Preferred Stock Dividends
June 20, 2023
From
XOMA Corporation
Via
GlobeNewswire
Recap: XOMA Q1 Earnings
May 09, 2023
XOMA (NASDAQ:XOMA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by 96.0%,...
Via
Benzinga
XOMA: Q1 Earnings Insights
May 09, 2023
XOMA (NASDAQ:XOMA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by 96.0%,...
Via
Benzinga
XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy
May 09, 2023
From
XOMA Corporation
Via
GlobeNewswire
XOMA to Present at H.C. Wainwright BioConnect Investor Conference
April 26, 2023
From
XOMA Corporation
Via
GlobeNewswire
XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio
March 30, 2023
Acquired IXINITY® commercial payment and milestone economics from Aptevo Therapeutics
From
XOMA Corporation
Via
GlobeNewswire
XOMA Declares Quarterly Preferred Stock Dividends
March 21, 2023
From
XOMA Corporation
Via
GlobeNewswire
XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy
March 09, 2023
From
XOMA Corporation
Via
GlobeNewswire
XOMA to Present at 43rd Annual Cowen Health Care Conference
February 28, 2023
From
XOMA Corporation
Via
GlobeNewswire
XOMA: Q3 Earnings Insights
November 03, 2022
XOMA (NASDAQ:XOMA) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:45 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 08, 2022
On Thursday, 168 companies reached new 52-week lows.
Via
Benzinga
XOMA Earnings Perspective: Return On Capital Employed
May 27, 2022
Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q1 sales of $3.11 million. Earnings fell to a loss of $2.28 million, resulting in a 107.64% decrease from last quarter. In Q4, XOMA earned $29.84 million,...
Via
Benzinga
XOMA's Return On Capital Employed Insights
March 10, 2022
According to Benzinga Pro, during Q4, XOMA (NASDAQ:XOMA) earned $29.84 million, a 772.77% increase from the preceding quarter. XOMA also posted a total of $35.94 million in sales...
Via
Benzinga
50 Biggest Movers From Yesterday
January 06, 2022
Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 04, 2022
During Wednesday's trading, 435 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 05, 2022
Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. Trading volume for this security as of 12:31 EST is...
Via
Benzinga
XOMA's Return On Capital Employed Overview
November 08, 2021
Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q3 sales of $940.00 thousand. Earnings fell to a loss of $3.35 million, resulting in a 9.17% decrease from last quarter. In Q2,...
Via
Benzinga
XOMA's Return On Capital Employed Overview
September 08, 2021
According to Benzinga Pro data, during Q2, XOMA (NASDAQ:XOMA) posted sales of $901.00 thousand. Earnings were up 52.33%, but XOMA still reported an overall loss of $3.06 million....
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.